94090 ⎘
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom Nitrogen atoms
SUBSTITUTED TETRACYCLINE COMPOUNDS
#2ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF
#3COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#4PHOSPHODIESTERASE INHIBITORS AND USES THEREOF
#5SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF
#62-PHENYL-3,4-DIHYDROPYRROLO[2,1 -F] [1,2,4]TRIAZINONE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS AND USES THEREOF
#7NEW PROCESS FOR THE SYNTHESIS OF 5-{5-CHLORO-2-[(3S)-3-[(MORPHOLIN-4-YL)METHYL]-3,4-DIHYDROISOQUINOLINE-2(1H)- CARBONYL]PHENYL}-1,2-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID DERIVATIVES AND ITS APPLICATION FOR THE PRODUCTION OF PHARMACEUTICAL COMPOUNDS
#8SYNTHESIS OF AN ANTIVIRAL AZASUGAR TRIPHOSPHATE
#9PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES
#10ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF
#11Tri-functional crosslinking reagents
#12Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations
#13AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND SODIUM CATIONS
#142-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
#15NITRIC OXIDE DONORS
#16SUBSTITUTED TETRACYCLINE COMPOUNDS
#17COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#18Carbocyclic prolinamide derivatives
#19SUBSTITUTED PYRROLIDINES AS FACTOR XIA INHIBITORS FOR THE TREATMENT THROMBOEMBOLIC DISEASES
#20Carbocyclic prolinamide derivatives
#212-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
#22Modulators of indoleamine 2,3-dioxygenase
#23COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#24Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations
#25Photoredox-catalyzed direct C-H functionalization of arenes
#26COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#27COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#28Nitric oxide donors
#29Activation of carbonyl beta-carbons for chemical transformations
#30Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases
#31Carbocyclic prolinamide derivatives
#322-pyrrolidine phenylhydrazides antibacterial agents
#33Derivatives of pyrrole-2,5-diones having a fungicidal activity, their agronomical compositions and use thereof
#34Methods of preparing tecovirimat
#35COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#36Tri-functional crosslinking reagents
#37Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-D]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA)
#382-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
#39Methods of preparing tecovirimat
#40SUBSTITUTED CYCLIC ARYL AND HETEROARYL CARBOXYLIC ACID HYDRAZIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS
#41Photoredox-catalyzed direct C—H functionalization of arenes
#42Methods of preparing Tecovirimat
#43Crystalline arylalkylamine compound and process for producing the same
#44Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases
#45Methods of preparing Tecovirimat
#46Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#47Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases
#48Bicyclic compounds
#49Crystalline 4-(3S-(1R-(1-napthyl)ethylamino)pyrrolidin-1-yl)phenylacetic acid
#50Pesticide
#51Methods of preparing Tecovirimat
#52Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A
#53Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases
#54Nitroxyl progenitor compounds and methods of use
#55Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations
#56Amide compound or salt thereof, biofilm inhibitor, biofilm remover and disinfectant containing the same
#573-AMINO LACTAMS AS ANTI-INFLAMMATORY AGENTS
#58NKantagonists
#59Anti-cancer agents
#60Apoptosis promoters
#61NONOate derivatives and uses thereof
#62Substituted tetracycline compounds
#63Anti-cancer agents
#64NK1 antagonists
#65Amide compound or salt thereof, and biofilm inhibitor, biofilm remover and disinfectant containing the same
#664-amino-N-hydroxy-benzamides for the treatment of cancer
#67Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
#68Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use
#69Apoptosis promoters
#70COMPOUNDS FROM MYCELIUM OF ANTRODIA CINNAMOMEA AND USE THEREOF
#71Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
#72Apoptosis promoters
#73NKantagonists
#74Compounds with anti-cancer activity
#75Substituted tetracycline compounds
#76Compounds from mycelium of and use thereof
#77METHODS FOR GENERATING HIGH TITER HELPER-FREE PREPARATIONS OF RELEASED RECOMBINANT AAV VECTORS
#78Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#79Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
#80Process for Synthesizing Nitramine Compounds
#81Nitroxyl progenitor compounds and methods of use
#82Prophylactic/Therapeutic Agent for Diabetes
#83METHODS OF TREATING P38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
#84Anti-Inflammatory Agents
#85DIAZENIUMDIOLATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, COMPOSITIONS THEREOF, AND RELATED METHODS
#86Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations
#87PREPARATION OF [2-METHYL-5-PHENYL-3-(PIPERAZIN-1-YLMETHYL)] PYRROLE DERIVATIVES
#88Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
#89Amide compound or salt thereof, and biofilm inhibitor, biofilm remover and disinfectant containing the same
#90Inhibitors for steroid response elements and related methods
#91Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
#92Compounds with anti-cancer activity
#93Methods for generating high titer helper-free preparations of released recombinant AAV vectors
#94Nitro-Substituted Phenyl-Piperazine Compounds, Their Preparation and Use in Medicaments
#95Protease inhibitors
#96Apoptosis promoters
#97Apoptosis promoters
#98Method for preparing pyrrolotriazine compounds via in situ amination of pyrroles
#99NKantagonists
#100Catalysts containing N-pyrrolyl substituted nitrogen donors
#101Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#102Novel nitrosation polymer in organic synthesis
#103Methods for the preparation of pyrrolotriazine compounds
#104Methods for generating high titer helper-free preparations of released recombinant AAV vectors
#105Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
#106Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
#107Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
#108Catalysts containing N-pyrrolyl substituted nitrogen donors